Oaktree Capital Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Oaktree Capital Management’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100,000	Closed	-$1.06M	–	239
2023 Q2	$1.06M	Hold	100,000	–	–	0.01%	225
2023 Q1	$1.04M	Hold	100,000	–	–	0.01%	274
2022 Q4	$1.03M	Hold	100,000	–	–	0.01%	313
2022 Q3	$1M	Hold	100,000	–	–	0.01%	341
2022 Q2	$1M	Hold	100,000	–	–	0.01%	319
2022 Q1	$988K	Buy	+100,000	New	+$987K	0.01%	318

Other funds holding BIOS

Westchester Capital Management (New York) Valhalla, New York $2.07B AUM 26.02% 1-Year Est. Return

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return